FDA Inspection
Xellia Pharmaceuticals USA LLCXellia Pharmaceuticals USA LLC – FDA Inspection, Sep 29, 2023
Record Details
This FDA Inspection record concerns Xellia Pharmaceuticals USA LLC, with an inspection on September 29, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · d8d9b38c-a723-4609-9dd4-0b9f92e5c364
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1220071
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 211.113(b)Validation lacking for sterile drug products
- 21 CFR 211.192Written record of investigation incomplete
- 21 CFR 211.113(b)Validation lacking for sterile drug products
- 21 CFR 211.192Written record of investigation incomplete
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Xellia Pharmaceuticals USA LLC
4| Date | Classification | Office | Project area |
|---|---|---|---|
| December 15, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 7, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 31, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 13, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Xellia Pharmaceuticals USA LLC
- FDA Inspection 1194565 - 2022-12-15
- FDA Inspection 1161837 - 2022-02-07
- FDA Inspection 1117006 - 2020-01-31
- FDA Inspection 990058 - 2016-10-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.